Microfluidics Technology in Viral Detection and Infectious Disease Research
In a short period of time, a novel coronavirus (SARS-CoV-2) has impacted our lives, society and health care infrastructure. In today's online seminar, we will provide examples of how Fluidigm products are supporting global laboratory efforts in response to COVID-19 to address critical needs for testing and clinical research by delivering:
- Versatile automated microfluidic systems that support multiple biomarker types (DNA, RNA and protein)
- Scalable throughput that enables the testing of more than 6,000 samples per day, with multiple targets of interest per sample
- Flexible panel designs that enable users to easily add, remove or change assays without changing technologies
- Cost-efficient workflows that minimize reagent consumption using microfluidics technology
During this webinar, we will explore how Fluidigm multi-omic solutions help enable interrogation of health and disease in comprehensive new ways. Whether you are seeking to gain new insights into coronavirus (SARS-CoV-2) viral detection or infectious disease research, or to accelerate therapeutic development, we can help you reach your goal.
About the presenters:
Bill Hunt, MS
Director, Microfluidics Product Management,
Steve Kain, PhD, MBA
Director, Genomics Product Management,
Senior Manager, Field Applications,
For Research Use Only. Not for use in diagnostic procedures.